Kyverna Therapeutics, Inc. KYTX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -74.5%-9.9pp | -64.7%— | —— | —— | —— | |
| Return on invested capital | -94.5%+21.9pp | -116.4%— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 8.1×+0.4× | 7.8×+2.6× | 5.2×-0.2× | 5.4×-2.1× | 7.4×-1.2× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $3.24-38.3% | $5.25+50.0% | $3.50-18.0% | $4.27-17.7% | $5.18-25.5% | |
| Valuation | ||||||
| Market capitalization | $498.52M+276% | $560.3M+116% | $259.47M+88.2% | $137.87M+65.5% | $83.32M-48.4% | |
| Price / book | 2.5×+2.0× | 2.4×+0.7× | 1.7×+1.0× | 0.7×+0.4× | 0.4×-0.2× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Kyverna Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Kyverna Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.